Advances towards curing HIV-1 infection from tissue reservoirs.
A disease of more than 39.6 million people world-wide, HIV-1 infection has no curative therapy. To date, one man has achieved a sterile cure, with millions more hoping to avoid the potential pitfalls of lifelong antiretroviral therapy and other HIV-related disorders, including neurocognitive decline. Recent developments in immunotherapies and gene therapies provide renewed hope in advancing efforts towards a sterilizing or functional cure. On the horizon is research concentrated in multiple separate, but potentially complementary domains: vaccine research, viral transcript editing, T-cell effector response targeting including check point inhibitors, and gene editing. Here we review the concept of targeting the HIV-1 tissue reservoirs with an emphasis on the central nervous system and describe relevant new work in functional cure research and strategies for HIV-1 eradication.